Literature DB >> 20151463

Myopathy and parkinsonism in phosphoglycerate kinase deficiency.

Evangelia Sotiriou1, Paul Greene, Sindu Krishna, Michio Hirano, Salvatore DiMauro.   

Abstract

A 25-year-old man with exertional myoglobinuria had no evidence of hemolytic anemia, but he had severe parkinsonism that was responsive to levodopa. Phosphoglycerate kinase (PGK) activity was markedly decreased in muscle, and molecular analysis of the PGK1 gene identified the p.T378P mutation that was recently reported in a patient with isolated myopathy. This case reinforces the concept that PGK deficiency is a clinically heterogeneous disorder and raises the question of a relationship between PGK deficiency and idiopathic juvenile Parkinson disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20151463      PMCID: PMC8285082          DOI: 10.1002/mus.21612

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

1.  Phosphoglycerate kinase deficiency: an adult myopathic form with a novel mutation.

Authors:  T Hamano; T Mutoh; H Sugie; H Koga; M Kuriyama
Journal:  Neurology       Date:  2000-03-14       Impact factor: 9.910

2.  Molecular abnormalities of a phosphoglycerate kinase variant generated by spontaneous mutation.

Authors:  M Maeda; E V Bawle; R Kulkarni; E Beutler; A Yoshida
Journal:  Blood       Date:  1992-05-15       Impact factor: 22.113

Review 3.  PGK deficiency.

Authors:  Ernest Beutler
Journal:  Br J Haematol       Date:  2007-01       Impact factor: 6.998

4.  Red cell phosphoglycerate kinase deficiency. A new cause of non-spherocytic hemolytic anemia.

Authors:  A P Kraus; M F Langston; B L Lynch
Journal:  Biochem Biophys Res Commun       Date:  1968-01-25       Impact factor: 3.575

5.  Erythrocyte and leukocyte phosphoglycerate kinase deficiency with neurologic disease.

Authors:  P N Konrad; D J McCarthy; A M Mauer; W N Valentine; D E Paglia
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

6.  Hereditary hemolytic anemia associated with phosphoglycerate kinase deficiency in erythrocytes and leukocytes. A probable X-chromosome-linked syndrome.

Authors:  W N Valentine; H S Hsieh; D E Paglia; H M Anderson; M A Baughan; E R Jaffé; O M Garson
Journal:  N Engl J Med       Date:  1969-03-06       Impact factor: 91.245

7.  A new case of phosphoglycerate kinase deficiency: PGK Creteil associated with rhabdomyolysis and lacking hemolytic anemia.

Authors:  R Rosa; C George; M Fardeau; M C Calvin; M Rapin; J Rosa
Journal:  Blood       Date:  1982-07       Impact factor: 22.113

8.  Molecular defect of a phosphoglycerate kinase variant associated with haemolytic anaemia and neurological disorders in a large kindred.

Authors:  G Turner; J Fletcher; J Elber; Y Yanagawa; V Davé; A Yoshida
Journal:  Br J Haematol       Date:  1995-09       Impact factor: 6.998

9.  Mutations for Gaucher disease confer high susceptibility to Parkinson disease.

Authors:  Jun Mitsui; Ikuko Mizuta; Atsushi Toyoda; Ryo Ashida; Yuji Takahashi; Jun Goto; Yoko Fukuda; Hidetoshi Date; Atsushi Iwata; Mitsutoshi Yamamoto; Nobutaka Hattori; Miho Murata; Tatsushi Toda; Shoji Tsuji
Journal:  Arch Neurol       Date:  2009-05

Review 10.  A novel missense mutation (1060G --> C) in the phosphoglycerate kinase gene in a Japanese boy with chronic haemolytic anaemia, developmental delay and rhabdomyolysis.

Authors:  Akira Morimoto; Ikuyo Ueda; Yoshiaki Hirashima; Yasuko Sawai; Tomohiro Usuku; Gen Kano; Kikuko Kuriyama; Shinjiro Todo; Tohru Sugimoto; Hitoshi Kanno; Hisaichi Fujii; Shinsaku Imashuku
Journal:  Br J Haematol       Date:  2003-09       Impact factor: 6.998

View more
  15 in total

Review 1.  Metabolic Myoglobinuria.

Authors:  Emanuele Barca; Valentina Emmanuele; Salvatore Billi DiMauro
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

2.  Levodopa Responsive Parkinsonism in Two Patients With Phosphoglycerate Kinase Deficiency.

Authors:  Tuhin Virmani; Michael Rotstein; Ronen Spiegel; Hasan O Akman; Salvatore DiMauro; Paul E Greene
Journal:  Mov Disord Clin Pract       Date:  2014-06-26

3.  A novel PGK1 mutation associated with neurological dysfunction and the absence of episodes of hemolytic anemia or myoglobinuria.

Authors:  Shigeto Matsumaru; Hirokazu Oguni; Hiromi Ogura; Keiko Shimojima; Satoru Nagata; Hitoshi Kanno; Toshiyuki Yamamoto
Journal:  Intractable Rare Dis Res       Date:  2017-05

Review 4.  Neuromuscular disorders of glycogen metabolism.

Authors:  Elisabetta Gazzerro; Antoni L Andreu; Claudio Bruno
Journal:  Curr Neurol Neurosci Rep       Date:  2013-03       Impact factor: 5.081

Review 5.  Skeletal muscle disorders of glycogenolysis and glycolysis.

Authors:  Richard Godfrey; Ros Quinlivan
Journal:  Nat Rev Neurol       Date:  2016-05-27       Impact factor: 42.937

Review 6.  Glycolysis: The Next Big Breakthrough in Parkinson's Disease.

Authors:  Unaiza Naeem; Abdul Rehman Arshad; Areesha Jawed; Farea Eqbal; Laiba Imran; Zayeema Khan; Farhat Ijaz
Journal:  Neurotox Res       Date:  2022-09-24       Impact factor: 3.978

7.  Insights into human phosphoglycerate kinase 1 deficiency as a conformational disease from biochemical, biophysical, and in vitro expression analyses.

Authors:  Angel L Pey; Maristella Maggi; Giovanna Valentini
Journal:  J Inherit Metab Dis       Date:  2014-05-17       Impact factor: 4.982

8.  Enhancing glycolysis attenuates Parkinson's disease progression in models and clinical databases.

Authors:  Rong Cai; Yu Zhang; Jacob E Simmering; Jordan L Schultz; Yuhong Li; Irene Fernandez-Carasa; Antonella Consiglio; Angel Raya; Philip M Polgreen; Nandakumar S Narayanan; Yanpeng Yuan; Zhiguo Chen; Wenting Su; Yanping Han; Chunyue Zhao; Lifang Gao; Xunming Ji; Michael J Welsh; Lei Liu
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

Review 9.  Progress and problems in muscle glycogenoses.

Authors:  S DiMauro; R Spiegel
Journal:  Acta Myol       Date:  2011-10

10.  Molecular insights on pathogenic effects of mutations causing phosphoglycerate kinase deficiency.

Authors:  Laurent R Chiarelli; Simone M Morera; Paola Bianchi; Elisa Fermo; Alberto Zanella; Alessandro Galizzi; Giovanna Valentini
Journal:  PLoS One       Date:  2012-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.